Target intelligence / Profile preview

50S ribosomal RNA of the bacterial large ribosomal subunit (50S rRNA)

Target
50S rRNA
Molecular classification
Ribosomal RNA, Ribozyme (RNA enzyme), Structural RNA, Catalytic RNA, Other: ribosome component
01

Overview

The 50S ribosomal RNA refers to the rRNA components (23S and 5S rRNA) of the larger subunit of the bacterial ribosome. The bacterial ribosome consists of two subunits: 30S (small, with 16S rRNA) and 50S (large, with 23S and 5S rRNA and 31 proteins). The 50S subunit rRNAs play essential roles in maintaining the ribosome’s structure and catalyzing peptide bond formation during translation. The 23S rRNA forms the peptidyl transferase center, responsible for the catalytic activity of peptide bond synthesis, while 5S rRNA stabilizes ribosome structure and helps with assembly. Many antibiotics target the 50S rRNA, inhibiting bacterial protein synthesis and serving as essential therapeutic agents in bacterial infections; resistance typically develops via mutations or chemical modifications of the rRNA. The 50S rRNA is not found in eukaryotes, which have a 60S large ribosomal subunit, providing selectivity for antibacterial drugs targeting this molecule.

Other names
23S ribosomal RNA5S ribosomal RNABacterial large ribosomal subunit rRNALSU rRNA (Large Subunit rRNA)50S ribosome rRNA
02

Mechanism of action

Inhibition of protein synthesis by binding to 50S rRNA and blocking peptide bond formation or translocation; Interference with ribosomal assembly or function; Disruption of tRNA binding

03

Biological functions

Protein synthesis (translation)Peptidyl transferase activity (catalyzing peptide bond formation)Ribosome assembly and structureOther: structural support for ribosome
04

Disease associations

Infection (targeted by antibiotics in bacterial infections)Other: resistance development in pathogens
05

Safety considerations

Off-target effects on mitochondrial ribosomes in humans (potential for toxicity, e.g. chloramphenicol)Resistance arising from rRNA mutations or methylationHypersensitivity/allergic reactions to ribosome-targeting antibioticsDisruption of normal gut flora
06

Interacting drugs

Macrolide antibiotics (e.g. erythromycin, clarithromycin)

6 more in the full profile.

07

Biomarkers

Mutations in 23S rRNA as markers for antibiotic resistance (especially for macrolides and linezolid)rRNA methylation status (in some resistance mechanisms)

Beyond the preview

Go deeper on 50S ribosomal RNA of the bacterial large ribosomal subunit (50S rRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 50S ribosomal RNA of the bacterial large ribosomal subunit (50S rRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call